baber/WOPTO huggingface dataset:
Patent FI-991451-A0 (FI)
IPC: H04L12/28
Filed: 1999-06-24
Abstract: A method of managing sessions (68, 70) between a plurality of mobile terminals and a server having a plurality of threads (74, 76) comprises grouping the sessions (70) into a plurality of groups (72) and assigning a server thread (74) to each group of sessions. The sessions are grouped by using a special thread (76) referred to as an acceptor thread. The sessions typically involve gathering information from the Internet.
Patent IL-59595-A0 (IL)
Title: Process for freeing phosphoric acid from organic contaminants
IPC: B01J23/54
Filed: 1980-03-12
Abstract: The invention relates to a process for freeing aqueous phosphoric acid solutions from organic contaminants. To this end, the solutions are admixed and reacted with hydrogen peroxide in the presence of a catalyst consisting of a noble metal or metal oxide being inert with respect to phosphoric acid or of a mixture of said noble metal and metal oxide.
Patent IL-66344-A0 (IL)
Title: Plasmid p svh 1 and its use
IPC: C12N15/00
Filed: 1982-07-19
Abstract: The plasmid p SVH 1, which is obtained from Streptomyces venezuelae DSM 40755 and which has a molecular weight of 8.4 megadaltons, a contour length of 4.1  mu m and a molecular size of 12.6 kilobases, and its use for the construction of a vector and for cloning foreign DNA in suitable host organisms.
Patent IL-71457-A0 (IL)
Title: Pyrimidine derivatives,their preparation and their use as microbicides
IPC: C07D239/46
Filed: 1984-04-06
Abstract: The invention relates to novel N-(2-nitrophenyl)-4-aminopyrimidine derivatives of the general formula I    <IMAGE>  (I)  wherein R1 is NO2 or CF3, R2 is NO2 or CF3, R3 is hydrogen or halogen, R4 is hydrogen or the -C(O)R7 group, wherein R7 is C1-C4alkyl which is unsubstituted or substituted by halogen, C1-C3alkoxy or C1-C3alkylthio, R5 and R6 are each independently halogen, C1-C6alkoxy, C1-C6alkyl which is substituted by halogen or C1-C3alkoxy, C1-C6alkoxy which is substituted by halogen or C1-C3alkoxy, C1-C6alkylthio or C1-C6alkylthio which is substituted by halogen or C1-C3alkoxy, or are C3-C6cycloalkoxy, C3-C6cycloalkylthio, C3-C6alkenyloxy, C3-C6alkenylthio, C3-C6alkynyloxy, C1-C6alkylsulfoxyl, C1-C6-alkylsulfonyl, C1-C6alkylsulfonyloxy, C3-C6alkenylsulfoxyl, C3-C6alkenylsulfonyl, C3-C6cycloalkylsulfoxyl or C3-C6cycloalkylsulfonyl. The invention relates further to methods of preparing these compounds as well as to agrochemical compositions which contain them. Also described is a method of controlling phytopathogenic micro-organisms with the aid of the novel compounds.
Patent IL-76012-A0 (IL)
Title: Constant volume lithium battery cell and process
IPC: H01M10/40
Filed: 1985-08-05
Abstract: @ A battery cell and a method for preparing a battery cell are disclosed in which a substantially fixed volume container includes the cell components therein in voltaic relationship, with the cell components including an anode comprising lithium metal, a non-aqueous electrolyte and a cathode in a spatial relationship to the anode within the fixed volume container, wherein the cathode comprises cathode active material which upon discharge intercalates lithium and undergoes a phase transition to a distinct structural phase in which phase the cathode active material can reversibly operate and which phase provides a cathode expansion greater than the anode volume decrease upon discharge, and wherein the spatial relationship and the cathode expansion within the substantially fixed volume are sufficient to produce a compressive load on the anode which inhibits the formation of a porous deposit of exterior, irregularly oriented, amalgamated lithium grains on the anode when the cell is reversibly operated with the cathode in said phase.
Patent IL-85603-A0 (IL)
Title: Synergistic interplay of lymphokines and double-stranded rnas
IPC: A61P37/00
Filed: 1988-03-01
Abstract: The unexpected synergistic interplay between lymphokines and dsRNAs which dramatically reduces the necessary dosages of lymphokines, especially IL-2, and simultaneously widens their therapeutic range in the treatment of various types of cancers, viral disorders or other body conditions characterized by disregulated immune states (e.g., autoimmune diseases). Specific combinations of dsRNA plus IL-2 significantly increase survival in human melanoma-bearing animals in part because of augmentation by dsRNA of lymphokine activated killer cells (LAK) which are first formed in response to IL-2 exposure. The invention has wide applicability to non-toxic, efficacious control of both human cancer and various human viral infections and immunoregulatory disorders.
Patent IL-94966-A0 (IL)
Title: Polymer base blend compositions containing destructurized starch
IPC: C08L3/00
Filed: 1990-07-04
Abstract: A composition of matter capable of being formed into articles having substantial dimensional stability comprising     a) destructurized starch, and b) at least one polymer selected from the group of copolymers containing vinyl alcohol units together with aliphatic chain units as are obtained by copolymerization of vinyl esters, preferably vinyl acetate, with unsaturated monomers containing no functional group with subsequent hydrolysis of the vinyl ester group.   The composition may contain further conventional additives as well as hydrophobic, substantially water-insoluble polymers.
Patent FI-20010337-A0 (FI)
Inventor: POUTANEN TORSTI
IPC: H04W24/00
Filed: 2001-02-21
Abstract: The invention relates to a method and device for performing channel simulation, the device comprising a set of channel simulation units ( 200 to 214 ) for simulating a radio channel, each unit comprising radio frequency parts ( 200 A to 214 A) and baseband parts ( 200 B to 214 B). In the solution of the invention, the baseband parts of several different units ( 200 to 214 ) are arranged to simulate the same channel.
Patent IL-107494-A0 (IL)
Title: Potentiator of bacillus pesticidal activity
IPC: A01N63/50
Filed: 1993-11-04
Abstract: The present invention relates to a factor that potentiates the pesticidal activity of a Bacillus related pesticide as well as methods for isolating and identifying said factor. The invention further relates to pesticidal compositions comprising the factor as well as methods of using the pesticidal compositions to control a pest and decrease the resistance of a pest to a pesticide and potentiate a Bacillus related pesticide. The factor of the present invention may be obtainable from a Bacillus fermentation. In a most specific embodiment said factor has the structure (Ia).
Patent IL-111398-A0 (IL)
Title: Band saw blade
IPC: B23D61/12
Filed: 1994-10-25
Abstract: An improved saw blade includes groups of saw teeth disposed along the cutting edge of the blade. Each group of teeth includes, in relation to the cutting direction of the blade, an unset leading tooth followed by two pairs of trailing teeth alternately set in opposite lateral directions outwardly of the centerline of the blade. The first pair of trailing teeth are generally of the same height as the leading tooth and the second pair of trailing teeth are shorter and have a substantially wider set than the first pair. The pair of trailing teeth that are shorter and wider set are disposed in consecutively and interposed relation between the first pair of trailing teeth. The set distance of the first pair of trailing teeth is approximately 50% of the set distance of the second pair of trailing teeth.
Patent IL-112330-A0 (IL)
Title: Agarose-coated secretory cells, methods for the preparation thereof, and pharmaceutical compositions containing the same
IPC: A61K47/26
Filed: 1995-01-13
Abstract: The present invention involves an agarose coated, agarose secretory cell macrobead, and an agarose coated, agarose-collagen secretory cell macrobead
Patent IL-118022-A0 (IL)
Title: Method for monitoring a signal to be transmitted via at least one telecommunication link a monitoring controlling device and processing means
IPC: H04Q11/04
Filed: 1996-04-23
Abstract: Prior art methods used for monitoring, via monitoring means, signals which are to be transmitted via telecommunication links and with said signals each comprising a signalling signal and a content signal, require that the processing means which are required for monitoring are either situated in the vicinity of the monitoring means or must be coupled to the monitoring means via leased-lines. By having the monitoring means generate a further signalling signal, dependent upon a code word related to a signalling signal, and consequently transmitting, dependent upon the further signalling signal, a content signal which is to be monitored to the processing means, a substantial more efficient method is obtained as both means can be coupled via a public telephony network. Furthermore, the possibility arises not only to transmit a content signal which is to be monitored to the processing means but also a signalling signal, especially if the telephony network is a so-called ISDN network which uses one or two B channels and one D channel for each telecommunication link which has been established and has to be monitored.
Patent IL-122739-A0 (IL)
Title: Galanthamine derivatives their preparation and pharmaceutical compositions containing them
IPC: C07D491/06
Filed: 1996-07-19
Abstract: PCT No. PCT/FR96/01139 Sec. 371 Date Jan. 9, 1998 Sec. 102(e) Date Jan. 9, 1998 PCT Filed Jul. 19, 1996 PCT Pub. No. WO97/03987 PCT Pub. Date Feb. 6, 1997Novel galanthamine derivatives of general fonnulae (Ia) and (Ib), a method for preparing same, pharmaceutical compositions containing said derivatives, and their use, in particular as cholinesterase inhibitors, are disclosed.
Patent IL-123196-A0 (IL)
Title: Biocompatible aqueous solution for use in continuous ambulatory peritoneal dialysis
IPC: A61K33/14
Filed: 1996-08-09
Abstract: The present invention relates to a peritoneal dialysis solution comprising at least one amino sugar in an effective amount sufficient to create an osmotic pressure to effect the removal of water by diffusion from the patient's blood across the peritoneal membrane into the solution. In one embodiment the at least one amino sugar is selected from the group consisting of acetylated amino sugars, preferably N-acetylglucosamine, deacetylated amino sugars and combinations thereof.
Patent IL-127193-A0 (IL)
Title: Antigen binding fragments that specifically detect cancer cells nucleotides encoding the fragments and use thereof for the prophylaxis and detection of cancers
IPC: A61K47/48
Filed: 1997-05-22
Abstract: The present invention relates to monoclonal antibody H11 and antigen binding fragments that specifically bind to the antigen recognized by H11, the C-antigen. The C-antigen is found specifically on neoplastic cells and not on normal cells. Also disclosed are polynucleotide and polypeptide derivatives based on H11, including single chain V region molecules and fusion proteins, and various pharmaceutical compositions. When administered to an individual, the H11 antibody is effective in diagnosing, localizing, and/or treating neoplasias. The invention further provides methods for treating a neoplastic disease, particularly melanoma, neuroblastoma, glioma, soft tissue sarcoma, and small cell lung carcinoma. Patients who are in remission as a result of traditional modes of cancer therapy may be treated with a composition of this invention in hopes of reducing the risk of recurrence. Patients may also be treated concurrently with the antibodies and traditional anti-neoplastic agents.
Patent IL-130249-A0 (IL)
Title: Meiosis regulating compounds
IPC: A61K31/575
Filed: 1997-12-19
Abstract: Certain compounds, structurally related to natural compounds which can be extracted i.a. from bull testes and from human follicular fluid, can be used for regulating the meiosis in oocytes and in male germ cells. Some of these compounds are useful in the treatment of infertility, whereas other compounds are useful as contraceptives. These compounds have the structural formula wherein the substituents are as defined in the specification.
Patent IL-132286-A0 (IL)
Title: Methods of diagnosing a medically resistant clinical subtype of ulcerative colitis and a kit for diagnosing the same
IPC: G01N33/569
Filed: 1998-04-09
Abstract: The present invention provides serological and genetic methods of diagnosing a medically resistant clinical subtype of ulcerative colitis UC. The present invention provides a method of diagnosing a medically resistant clinical subtype of UC by determining the presence or absence of anti-Saccharomyces cerevisiae antibodies (ASCA) in a patient with UC, where the presence of ASCA indicates the medically resistant clinical subtype of UC. The present invention also provides a method of diagnosing a medically resistant clinical subtype of UC by determining the presence or absence of a TNFa2b1c2d4e1 haplotype in a patient with UC, where the presence of said TNFa2b1c2d4e1 haplotype indicates the medically resistant clinical subtype of UC. In addition, the invention provides a method of diagnosing a medically resistant clinical subtype of UC by determining the presence or absence of a TNFa2b1c2d4e1 haplotype in a patient with UC and determining the presence or absence of ASCA in the patient with UC, where the presence of said TNFa2b1c2d4e1 haplotype indicates the medically resistant clinical subtype of UC and the presence of ASCA independently indicates the medically resistant clinical subtype of UC. The invention further provides kits for diagnosing a medically resistant clinical subtype of UC containing antigen specific for ASCA and one or more oligonucleotide primers complementary to a nucleotide sequence flanking TNF microsatellite locus TNFa, TNFb, TNFc, TNFd or TNFe.
Patent IL-132547-A0 (IL)
Title: A composition and method for reducing noise and/or fouling in a liquid cooling system
IPC: F02B77/13
Filed: 1998-04-24
Abstract: A composition for use in reducing noise in a liquid-cooling system of an engine, eg an automotive engine, comprising an organo-polymeric microfibril material insoluble in the cooling liquid of the liquid-cooling system. Preferably the microfibril material is contained in a carrier, which maybe in the form of a liquid, a gel or a compressed tablet soluble or dispersible in the cooling liquid.
Patent IL-136839-A0 (IL)
Title: Pharmaceutical compositions comprising cannabidiol derivatives
IPC: A61K31/222
Filed: 2000-06-16
Abstract: The present invention relates to cannabidiol derivatives and to pharmaceutical compositions comprising cannabidiol derivatives being antiinflammatory agents having analgesic, antianxiety, anticonvulsive, neuroprotective, antipsychotic and anticancer activity. The present invention also relates to a process for the preparation of cannabidiol derivatives. It also relates to the use of cannabidiol derivatives and of pharmaceutical compositions comprising same in the preparation of a medicament, in a method of the treatment of human beings with cannabidiol derivatives or with a pharmaceutical preparations comprising same.
Patent IL-137400-A0 (IL)
Title: Solid fuel additive
IPC: C10L1/10
Filed: 1999-02-05
Abstract: Solid or pasty fuel additive compositions comprise a homogeneous mixture of a solid compacting agent soluble in fuel and at least one liquid fuel additive, the compositions having an additive content of from more than about 40 to 99% by weight, based on their total weight.
Patent IL-143007-A0 (IL)
Title: Retrievable intravascular support structures
IPC: A61F2/07
Filed: 2001-05-07
Abstract: An intravascular platform for supporting an intravascular device includes two loops of wire each configured to assume a shape lying generally on a virtual cylinder of given diameter. The two loops are interconnected by at least one connecting wire which maintains the loops axially spaced from each other. Also disclosed are axially-extended loop forms, and associated intravascular devices.
Patent IL-143040-A0 (IL)
Title: A process for producing particles with a converted amorphous and/or meta-stable crystalline region into crystaline state
IPC: C07C31/18
Filed: 1999-11-22
Abstract: The invention provides a process for crystallization of amorphous and/or meta-stable crystalline regions of preformed particles by treating the particles with a supercritical or subcritical fluid containing an anti-solvent and a solvent. The invention further provides formulations comprising particles produced according to the present process containing one or more pharmacologically active substances and one or more pharmaceutically acceptable excipients, use of said formulations in the treatment of an allergic and/or inflammatory condition of the nose or lungs and methods for treatment of such conditions.
Patent IL-149006-A0 (IL)
Title: Reversed-phase hplc for plasminogen activators
IPC: G01N30/06
Filed: 2000-11-01
Abstract: A process is described for monitoring the effectiveness of a purification process in removing plasminogen activator (PA) endogenous to Chinese hamster ovary (CHO) cells from a sample containing human tPA or variants thereof. This process comprises incubating the sample with a protease capable of specifically cleaving the Arg275-Ile276 bond of human wild-type tPA and then with denaturing/reducing agents in respective amounts effective to reduce the disulfide bonds of human wild-type tPA; subjecting the sample to a reversed-phase high-performance liquid chromatography step, and analyzing the elution profile from the chromatography step for the amount of PA endogenous to the CHO cells present therein.
Patent IL-153019-A0 (IL)
Title: Pallet container
IPC: B65D77/06
Filed: 2001-05-23
Abstract: The invention relates to a palette container (10) comprising a thin-walled rigid inner container (12) made of thermoplastic synthetic material for storing and transporting liquid or flowable filling products. The inventive palette container also comprises a grid tube frame (14) which, as a support casing, closely surrounds the plastic container (12), and comprises a base palette (16) on which the plastic container (12) rests and to which the support casing is firmly attached. The grid tube frame (14) consists of vertical and horizontal tubular rods (30, 32) that are welded to one another at points of intersection (36). Several prior art palette containers exhibit substantial shortcomings (grid tube fatigue fracture) when subjected to prolonged dynamic vibrational stress that occurs, for example, during persistent stresses caused by the transport on roads of poor quality. The aim of the invention is to achieve an adapted optimal vibrational elasticity in order to improve the stability of the grid frame while providing a sufficient degree of flexural strength. To this end, the tubular rods (30, 32) have a closed profile (18) with a particular trapezoidal cross-section.
Patent IL-153963-A0 (IL)
Title: Proportional volumetric injector-dispenser
IPC: F04B13/00
Filed: 2001-07-13
Abstract: An injector dispenser comprises a chamber (1) with two main sections (1a, 1b) of different diameter inside wich moves a primary piston (3) with zones (3a, 3b) of different diameter, with the piston body (3) being traversed by a slide (17), provided moreover with a secondary cylinder (12) and magnetic device of positioning and locking of driven flow that act as a stop on the slide (17), that includes inside it a pair of discs (18, 19) situated at the ends. A pump is achieved with a less complex structure and greater precision in the dispensing of the liquids to be supplied and using less energy.
Patent IL-158729-A0 (IL)
Title: Channel quality measurements for downlink resource allocation
IPC: H04B7/005
Filed: 2002-05-14
Abstract: A method implemented by a user equipment, UE, the method comprising determining a first measurement value based on at least a first measurement taken during at least a first time interval; determining a second measurement value based on at least on a second measurement taken during at least a second time interval; and sending a measurement report to a base station, wherein the measurement report comprises an indication of the first measurement value and a difference indication for the second measurement value, wherein the difference indication for the second measurement value indicates a difference of the second measurement value relative to the first measurement value.
Patent IL-159864-A0 (IL)
Title: Portable device and method of communicating medical data information
IPC: H04L12/56
Filed: 2002-08-12
Abstract: This invention relates to a portable medical device (100) for communication of medical data information comprising a medical device part (101) comprising a first processor (104) and first storage means (103), and means (106) for executing one or more medical related functions, a communication device part (102) comprising a second processor (104'), second storage means (103'), and communication means (105), where the medical device part (101) and the communication device part (102) is connected allowing for exchange of data information according to a predetermined protocol, where the exchange of communication is under the control (109) of the medical device part (101) and where the functionalities of each device part otherwise is separated.
Patent IL-160453-A0 (IL)
Title: Flooring and method for laying and manufacturing the same
IPC: E04F15/04
Filed: 2002-09-20
Abstract: In a flooring with quadrangular floorboards that are mechanically lockable in a herringbone pattern, two different types of floorboards (A,B) are provided, the connecting means of one type of floorboard (A) along one pair of opposite edge portions being arranged in a mirror-inverted manner relative to the corresponding connecting means along the same pair of opposite edge portions of the other type of floorboard (B).
Patent IL-177886-A0 (IL)
Title: Combined peripheral and central rewinding machine
IPC: B65H18/26
Filed: 2006-09-04
Abstract: The rewinding machine comprises: a first winding roller (11) and a second winding roller (13) defining a nip (15) through which said cores are inserted and through which said web material (N) is fed; and at least one pair of motorized engaging members (57), to engage the ends of a winding core and transmit a rotational movement to the core during at least part of the winding cycle of each log. The engaging members and the first and second winding roller are produced and disposed so that the log being formed is in contact with said first and said second winding roller. Moreover, a third winding roller (17) is provided, defining a winding space with said first and said second winding roller, said third winding roller being movable to allow increase and completion of winding of each log in said winding space.
Patent IL-190894-A0 (IL)
Title: Device for preparing hot water and coffee machine provided with such a device
Filed: 2008-04-15
Abstract: The invention relates to a device for preparing hot water provided with a pressure pump with a supply pipe for supplying relatively cold water to the pressure pump and an outlet connected to a heating pipe which is in heat-exchanging contact with a heating body, with an outlet valve in the heating pipe and a coffee holder, connected to the heating pipe, for accommodating a bed of coffee, whereby the heating body comprises a reservoir that is openly connected to the environment, with a heating element and water in the reservoir as a heat-exchange medium. A by-pass pipe (54) connects the inlet (57) and outlet (35) of the pressure pump (34) to each other, with a pressure-operated valve (56) in the by-pass pipe.
Patent IL-197035-A0 (IL)
Title: Pharmaceutical formula for treating skin disease
Filed: 2009-02-12
Abstract: The present invention refers to a pharmaceutical formulation characterized in that it includes mainly clobetasolpropionate, minoxidil and 11 alpha hydroxyprogesterone as main active principles, besides other excipients, vitamins and/or minerals, and to its use in the treatment of skin diseases, mainly in the symptomatic treatment of psoriasis.